Govt Cracks Whip On Medical Device Makers, Importers

New Delhi : Concerned over quality and safety, the Centre has directed all manufacturers and importers of Class A medical devices to display the generic name, brand name, intended use, material of construction and shelf life of the product.

These devices, classified as non-sterile and low-risk, include catheters, disposable perfusion sets and surgical dressings among others. The Govt said this information also has to be shared on its “Online System of Medical Devices.”

Earlier, it was not mandatory for manufacturers to share the specific details with the Govt.

In the new notification, the Centre has proposed registration of Class A category medical devices, thus making these pharma products registered through an identified online portal established for this purpose.

“The manufacturers of a medical device shall upload the information such as name & address of manufacturing site, details of medical device, generic name, brand name, model number, intended use, dimension, shelf life and material of construction. Further, the manufacturers and importer shall self-certify that the product is conforming to the essential principles‘ checklist of safety and performance of such devices and comply to the standards prescribed in the medical device rules, 2017,” said the notification.

“Besides, this manufacturer or importer has to maintain the records of manufacturing/import along with its sales or distribution and should present the records before licensing authority as and when required. The licensing authorities can verify the records and documents at any point of time and investigate quality or safety related failures or complaints,” the document stated.

In India, medical devices are classified into four categories—with class A being the low-risk medical devices, class B low-moderate risk, class C moderate-high risk and Class D high-risk.

Makers of class D equipment have to follow a stringent procedure to get licenses for manufacturing.

Queries sent to health ministry spokespeople did not elicit a response.

 

  • Related Posts

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    New Delhi: Food regulator FSSAI has suspended the licence of Dior Pharmaceuticals for multiple violations at its nutraceutical factory. In a social media post on Thursday, FSSAI observed “serious non-compliances”…

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    Additional chief secretary (ACS), health, Sumita Misra said of these, 12 arrests have been made by FDA, Gurugram, which has also busted multiple interstate counterfeit medicine syndicates, seized fake medicines…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    Haryana intensifies crackdown on spurious drugs, FDA records 16 arrests in 10 months

    FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims

    FSSAI Issues Prohibition Orders against FOLINEURO Syrup and Neuherbs TRUE VITAMIN over Misleading Claims

    Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

    Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

    Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

    Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    13 Years after Oxytocin Order, HC Seeks Compilance Status